Correlation Between Olema Pharmaceuticals and Vanguard Index

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Olema Pharmaceuticals and Vanguard Index at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Olema Pharmaceuticals and Vanguard Index into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Olema Pharmaceuticals and Vanguard Index Trust, you can compare the effects of market volatilities on Olema Pharmaceuticals and Vanguard Index and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Olema Pharmaceuticals with a short position of Vanguard Index. Check out your portfolio center. Please also check ongoing floating volatility patterns of Olema Pharmaceuticals and Vanguard Index.

Diversification Opportunities for Olema Pharmaceuticals and Vanguard Index

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Olema and Vanguard is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Olema Pharmaceuticals and Vanguard Index Trust in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanguard Index Trust and Olema Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Olema Pharmaceuticals are associated (or correlated) with Vanguard Index. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanguard Index Trust has no effect on the direction of Olema Pharmaceuticals i.e., Olema Pharmaceuticals and Vanguard Index go up and down completely randomly.

Pair Corralation between Olema Pharmaceuticals and Vanguard Index

Given the investment horizon of 90 days Olema Pharmaceuticals is expected to under-perform the Vanguard Index. In addition to that, Olema Pharmaceuticals is 3.36 times more volatile than Vanguard Index Trust. It trades about -0.14 of its total potential returns per unit of risk. Vanguard Index Trust is currently generating about -0.07 per unit of volatility. If you would invest  9,534  in Vanguard Index Trust on July 7, 2022 and sell it today you would lose (285.00)  from holding Vanguard Index Trust or give up 2.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Olema Pharmaceuticals  vs.  Vanguard Index Trust

 Performance (%) 
       Timeline  
Olema Pharmaceuticals 
Olema Performance
0 of 100
Over the last 90 days Olema Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in November 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Olema Price Channel

Vanguard Index Trust 
Vanguard Performance
0 of 100
Over the last 90 days Vanguard Index Trust has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Vanguard Index is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Vanguard Price Channel

Olema Pharmaceuticals and Vanguard Index Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Olema Pharmaceuticals and Vanguard Index

The main advantage of trading using opposite Olema Pharmaceuticals and Vanguard Index positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Olema Pharmaceuticals position performs unexpectedly, Vanguard Index can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanguard Index will offset losses from the drop in Vanguard Index's long position.
Olema Pharmaceuticals vs. Tav Havalimanlari
Olema Pharmaceuticals vs. Hna Infrastructure Co
Olema Pharmaceuticals vs. Flughafen Zuerich Ag
Olema Pharmaceuticals vs. Grupo Aeroportuario Del
The idea behind Olema Pharmaceuticals and Vanguard Index Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Vanguard Index vs. Walt Disney
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go